The Scientist - Home

When tumor cells are infected with an oncolytic virus carrying a modified CD19 gene, they become targets for CAR T cells engineered to recognize this molecular marker.

The hold will likely delay trial results, and scientists say the pause is proof that safety protocols in clinical trials are working as they should.

Adenovirus vectors deliver the genetic instructions for SARS-CoV-2 antigens directly into patients’ cells, provoking a robust immune response. But will pre-existing immunity from common colds take them down?

The COVID Symptom Study app aims to help patients and healthcare providers identify patterns in user-reported data.

The International Commission on the Clinical Use of Human Germline Genome Editing claims the technology is still too risky for therapeutic use.

A meta-analysis of seven randomized controlled trials concludes that dexamethasone and other corticosteroids reduce 28-day mortality in seriously ill patients.

After six months, patients with fast-progressing amyotrophic lateral sclerosis who had received the experimental treatment had less loss of function than those who received a placebo.

The results from a study in Iceland can’t say if a recovered patient’s antibodies can protect them from subsequent reinfection.

Researchers are adapting CRISPR, synthetic biology, and other creative approaches to detect SARS-CoV-2 nucleic acids outside of the lab or doctors’ offices, in the hopes of making diagnostics more affordable and accessible.

A new genetic analysis confirms prior sightings in New Guinea.

An online conspiracy theory retweeted by President Donald Trump misconstrued data regarding the number of people who have died from the coronavirus.

Two gene variations might help explain why some people experience chronic wounds.